171 related articles for article (PubMed ID: 18006286)
1. Detection of surface bound complement at increasing serum anticoagulant concentrations.
Arvidsson S; Askendal A; Lindahl TL; Tengvall P
Colloids Surf B Biointerfaces; 2008 Apr; 62(2):214-9. PubMed ID: 18006286
[TBL] [Abstract][Full Text] [Related]
2. Immune complement activation on polystyrene and silicon dioxide surfaces. Impact of reversible IgG adsorption.
Sellborn A; Andersson M; Hedlund J; Andersson J; Berglin M; Elwing H
Mol Immunol; 2005 Mar; 42(5):569-74. PubMed ID: 15607815
[TBL] [Abstract][Full Text] [Related]
3. Blood plasma contact activation on silicon, titanium and aluminium.
Arvidsson S; Askendal A; Tengvall P
Biomaterials; 2007 Mar; 28(7):1346-54. PubMed ID: 17156838
[TBL] [Abstract][Full Text] [Related]
4. Complement activation on solid surfaces as determined by C3 deposition and hemolytic consumption.
Liu L; Elwing H
J Biomed Mater Res; 1994 Jul; 28(7):767-73. PubMed ID: 8083244
[TBL] [Abstract][Full Text] [Related]
5. [Complement activation in heparin--plasma inhibitory effect of anticoagulants on serum complement activation, 2nd report].
Kobayashi E; Kitano E; Kondo H; Kitamura H
Rinsho Byori; 2000 Jan; 48(1):60-6. PubMed ID: 10756677
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal circulation: in vivo and in vitro analysis of complement activation by heparin-bonded surfaces.
Kirschfink M; Kovacs B; Mottaghy K
Circ Shock; 1993 Jul; 40(3):221-6. PubMed ID: 8348684
[TBL] [Abstract][Full Text] [Related]
7. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface.
Andersson J; Ekdahl KN; Lambris JD; Nilsson B
Biomaterials; 2005 May; 26(13):1477-85. PubMed ID: 15522749
[TBL] [Abstract][Full Text] [Related]
8. Blood protein interactions with chromium surfaces.
Wälivaara B; Askendal A; Krozer A; Lundström I; Tengvall P
J Biomater Sci Polym Ed; 1996; 8(1):49-62. PubMed ID: 8933290
[TBL] [Abstract][Full Text] [Related]
9. Effects of fondaparinux compared with dalteparin, enoxaparin and unfractionated heparin on human osteoblasts.
Matziolis G; Perka C; Disch A; Zippel H
Calcif Tissue Int; 2003 Oct; 73(4):370-9. PubMed ID: 12874702
[TBL] [Abstract][Full Text] [Related]
10. Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation.
Mollnes TE; Garred P; Bergseth G
Clin Exp Immunol; 1988 Sep; 73(3):484-8. PubMed ID: 2463123
[TBL] [Abstract][Full Text] [Related]
11. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface.
Nakao M; Miura C; Itoh S; Nakahara M; Okumura K; Mutsuro J; Yano T
Fish Shellfish Immunol; 2004 Feb; 16(2):139-49. PubMed ID: 15123318
[TBL] [Abstract][Full Text] [Related]
12. Blood protein interactions with titanium surfaces.
Wälivaara B; Askendal A; Lundström I; Tengvall P
J Biomater Sci Polym Ed; 1996; 8(1):41-8. PubMed ID: 8933289
[TBL] [Abstract][Full Text] [Related]
13. Complement activation by IgG immobilized on methylated silicon.
Tengvall P; Askendal A; Lundström I
J Biomed Mater Res; 1996 Jul; 31(3):305-12. PubMed ID: 8806055
[TBL] [Abstract][Full Text] [Related]
14. Hirudin versus heparin for use in whole blood in vitro biocompatibility models.
Bexborn F; Engberg AE; Sandholm K; Mollnes TE; Hong J; Nilsson Ekdahl K
J Biomed Mater Res A; 2009 Jun; 89(4):951-9. PubMed ID: 18470919
[TBL] [Abstract][Full Text] [Related]
15. Effect of anticoagulant and blood storage time on platelet-bound antibody concentrations in clinically normal dogs.
Lewis DC; Meyers KM
Am J Vet Res; 1994 May; 55(5):602-5. PubMed ID: 8067605
[TBL] [Abstract][Full Text] [Related]
16. Complement activation on surfaces carrying amino groups.
Toda M; Kitazawa T; Hirata I; Hirano Y; Iwata H
Biomaterials; 2008 Feb; 29(4):407-17. PubMed ID: 17950841
[TBL] [Abstract][Full Text] [Related]
17. Anti-alphaGal-dependent complement-mediated cytotoxicity in metastatic melanoma.
Larkin JM; Norsworthy PJ; A'Hern RP; Eisen TG; Gore ME; Porter CD
Melanoma Res; 2006 Apr; 16(2):157-63. PubMed ID: 16567971
[TBL] [Abstract][Full Text] [Related]
18. In vitro plasma protein adsorption and kallikrein formation on 3-mercaptopropionic acid, L-cysteine and glutathione immobilized onto gold.
Lestelius M; Liedberg B; Lundström I; Tengvall P
J Biomed Mater Res; 1994 Aug; 28(8):871-80. PubMed ID: 7983086
[TBL] [Abstract][Full Text] [Related]
19. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
[TBL] [Abstract][Full Text] [Related]
20. [Complement activation in citrate plasma--inhibitory effect of anticoagulants on serum complement activation].
Kobayashi E; Kitano E; Kondo H; Kitamura H
Rinsho Byori; 1999 Feb; 47(2):160-4. PubMed ID: 10097633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
